Atlas Trials

Temsirolimus in Combination With Gemcitabine in Previously Untreated Metastatic Pancreatic Cancer

Clinical trial NCT00593008 · TERMINATED

Trial details

NCT number
NCT00593008
Sponsor
Massachusetts General Hospital
Status
TERMINATED
Phase
Phase 1
Study type
INTERVENTIONAL
Pancreatic Adenocarcinoma
Start date
2007-10-01
Primary completion
2009-10-01
Enrollment
5

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.